Sunshine Biopharma announces 1-for-20 reverse stock split effective Oct. 26

SBFM•2026-10-22

Sunshine Biopharma will implement a 1-for-20 reverse stock split at market open on Oct. 26, 2026, to regain compliance with Nasdaq’s minimum bid price requirement. Its issued and outstanding common shares will decrease from 15,219,383 to approximately 760,969.

Sunshine Biopharma announces 1-for-20 reverse stock split effective Oct. 26

1. Reverse split details

Related News

Korn Ferry: 77% of leaders see skills gaps outweighing talent shortages in 2027

Baird raises Biohaven target price to $48 from $42

Plumas Bancorp names Kelsey Cassinelli CFO, effective Jan. 1, 2027

U.S. stocks on the move: Quest Diagnostics, Tractor Supply, Dutch Bros

Allot holds annual general meeting of shareholders